TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2878741

Group type: EXPERIMENTAL
Intervention: pindolol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: propranolol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: metoprolol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 31895722

Group type: EXPERIMENTAL
Intervention: Loperamide and manometry-assisted biofeedback exercises
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo and educational pamphlet
Number of subjects: 296
Study: 29634425

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 26431470

Group type: EXPERIMENTAL
Intervention: AFN-1252 200 mg single dose in fed versus fasted subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AFN-1252 200, 300, and 400 mg doses administered once-daily for 10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AFN-1252 (all doses)
Number of subjects: 0
Study: 24992845

Group type: EXPERIMENTAL
Intervention: PerioGlas (particulate form)
Number of subjects: 28

Group type: COMPARATOR
Intervention: NovaBone Dental Putty (putty form)
Number of subjects: 28
Study: 23732254

Group type: EXPERIMENTAL
Intervention: Insecticide-treated curtains (ITCs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-treated curtains (NTCs)
Number of subjects: 0
Study: 20804678

Group type: EXPERIMENTAL
Intervention: Melanoscan comprehensive cutaneous photography system
Number of subjects: 53
Study: 18199693

Group type: EXPERIMENTAL
Intervention: Daclizumab (group D)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Thymoglobulin (group T)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Daclizumab (group D) without chemoprophylaxis
Number of subjects: 109

Group type: COMPARATOR
Intervention: Thymoglobulin (group T) without chemoprophylaxis
Number of subjects: 109
Study: 16430413

Group type: EXPERIMENTAL
Intervention: Morphine gel (0.2 mg.kg(‐1), 1 mg.ml(‐1))
Number of subjects: 120

Group type: COMPARATOR
Intervention: Morphine solution in saline (0.2 mg.kg(‐1), 1 mg.ml(‐1))
Number of subjects: 120
Study: 12975069

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 84

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 84
Study: 11107681

Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb‐IIIa receptor inhibitors
Number of subjects: 0
Study: 8602715

Group type: EXPERIMENTAL
Intervention: Cholesterol reduction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screening with total cholesterol levels
Number of subjects: 0
Study: 1327177

Group type: EXPERIMENTAL
Intervention: High protein diet (Group A)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Special diet for patients with intolerance to glucose (Group B)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 35
Study: 3862608

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) - 600 mg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ambroxol (AMB) - 90 mg/day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30894192

Group type: EXPERIMENTAL
Intervention: Steepest gradients-based training (N = 7)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard 'centre-out' reaching training (N = 9)
Number of subjects: 16
Study: 29210916

Group type: EXPERIMENTAL
Intervention: Higher-intensity exercise (70% peak power output)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (40% peak power output)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (rest)
Number of subjects: 20
Study: 26774901

Group type: EXPERIMENTAL
Intervention: Intra-articular autologous PRP injection
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no PRP injection)
Number of subjects: 30
Study: 25126978

Group type: EXPERIMENTAL
Intervention: Perineal protection device
Number of subjects: 1148

Group type: COMPARATOR
Intervention: Control group (no device)
Number of subjects: 1148
Study: 20056436

Group type: EXPERIMENTAL
Intervention: Remifentanil (1 μg/kg bolus followed by a 0.5 μg/kg/min infusion for 30 minutes after induction but before sternotomy)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 40
Study: 19001213

Group type: EXPERIMENTAL
Intervention: Femtosecond laser-created flaps
Number of subjects: 43

Group type: COMPARATOR
Intervention: Mechanical keratome-created flaps
Number of subjects: 43
Study: 15975980

Group type: EXPERIMENTAL
Intervention: Paired associative stimulation (PAS) applied to the common peroneal nerve during the swing phase of walking
Number of subjects: 14
Study: 12846706

Group type: EXPERIMENTAL
Intervention: Inhalation induction with sevoflurane
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous induction with thiopental
Number of subjects: 100
Study: 11764112

Group type: EXPERIMENTAL
Intervention: 32% phosphoric acid etching
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bonding system and fiber posts
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (Group 2) - SEM examination without further treatment
Number of subjects: 30
Study: 8804878

Group type: EXPERIMENTAL
Intervention: Acetorphan (100-300 mg thrice daily)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Octreotide (50-150 micrograms thrice daily)
Number of subjects: 13
Study: 1299252

Group type: EXPERIMENTAL
Intervention: Heat-treated resin composite inlay (7.5 minutes at 125 degrees C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-heat-treated resin composite inlay
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All restorations (heat-treated and non-heat-treated)
Number of subjects: 60
Study: 6698743

Group type: EXPERIMENTAL
Intervention: Topical imipramine 0.05%
Number of subjects: 27

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 27
Study: 30654777

Group type: EXPERIMENTAL
Intervention: Interactive website for people at familial risk for depression
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control website
Number of subjects: 202
Study: 30193579

Group type: EXPERIMENTAL
Intervention: Prophylactic subcutaneous scopolaminebutyl
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 26765472

Group type: EXPERIMENTAL
Intervention: McGrath Series 3 videolaryngoscope
Number of subjects: 180
Study: 25458333

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Internet-based blood glucose monitoring (IBGM)
Number of subjects: 40
Study: 22129855

Group type: EXPERIMENTAL
Intervention: Zinc- and micronutrient-rich food supplementation
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Ayurvedic zinc (Jasad) tablets
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 180
Study: 19766734

Group type: EXPERIMENTAL
Intervention: Counselor initiated tobacco quit line with 6 scheduled telephone sessions and 8 weeks of nicotine replacement therapy (NRT)
Number of subjects: 950

Group type: COMPARATOR
Intervention: Participant initiated tobacco quit line with 6 scheduled telephone sessions and 2 weeks of nicotine replacement therapy (NRT)
Number of subjects: 950
Study: 17344030

Group type: EXPERIMENTAL
Intervention: Hypericum extract (W55570) 300 mg t.i.d
Number of subjects: 375

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 375
Study: 16779058

Group type: EXPERIMENTAL
Intervention: McMaster PLUS interface 1
Number of subjects: 200

Group type: COMPARATOR
Intervention: McMaster PLUS interface 2
Number of subjects: 200
Study: 11862898

Group type: EXPERIMENTAL
Intervention: Lingual nerve protection during germectomies
Number of subjects: 300

Group type: COMPARATOR
Intervention: No lingual nerve protection during germectomies
Number of subjects: 300
Study: 9574879

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (FPANS) 200 microg, once daily for 7 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 7812088

Group type: EXPERIMENTAL
Intervention: Titrated trabeculectomy technique (tight scleral flap, 10/0 nylon sutures, argon laser lysis)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Traditional trabeculectomy technique
Number of subjects: 128
Study: 2958047

Group type: EXPERIMENTAL
Intervention: 123I hippuran
Number of subjects: 0

Group type: COMPARATOR
Intervention: 131I hippuran
Number of subjects: 0
Study: 31973615

Group type: EXPERIMENTAL
Intervention: Food supplementation with nutraceuticals (vitamins, oligo-minerals, plant extracts, essential amino- and fatty acids)
Number of subjects: 0
Study: 30055591

Group type: EXPERIMENTAL
Intervention: Care and treatment services for PLHIV
Number of subjects: 671
Study: 26856228

Group type: EXPERIMENTAL
Intervention: Culprit lesion only percutaneous coronary intervention (PCI) with possible staged non-culprit lesion revascularization
Number of subjects: 706

Group type: COMPARATOR
Intervention: Immediate multivessel PCI
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: Culprit lesion only PCI
Number of subjects: 706
Study: 23945035

Group type: EXPERIMENTAL
Intervention: 6-month resistance training intervention
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 23911247

Group type: EXPERIMENTAL
Intervention: Thoracic endovascular aortic repair (TEVAR)
Number of subjects: 60784

Group type: EXPERIMENTAL
Intervention: Lower SES
Number of subjects: 60784

Group type: COMPARATOR
Intervention: Open thoracic aortic repair
Number of subjects: 60784
Study: 20434864

Group type: EXPERIMENTAL
Intervention: HAHA program (integrated health education and exercise program)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 40
Study: 18363894

Group type: EXPERIMENTAL
Intervention: MMX mesalazine 2.4 g/day
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: MMX mesalazine 4.8 g/day
Number of subjects: 517

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 517
Study: 16423144

Group type: EXPERIMENTAL
Intervention: Caffeine (50 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 12915252

Group type: EXPERIMENTAL
Intervention: 2-Hz electrical acupoint stimulation (EAS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 100-Hz electrical acupoint stimulation (EAS)
Number of subjects: 0
Study: 10702430

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (4 ppm)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Prostaglandin E(1) infusion (8 ng/kg/min)
Number of subjects: 68
Study: 9116784

Group type: EXPERIMENTAL
Intervention: Warmed circulating-water blanket
Number of subjects: 76

Group type: COMPARATOR
Intervention: Warmed convective-air blanket
Number of subjects: 76
Study: 7682395

Group type: EXPERIMENTAL
Intervention: Hyperthermo-chemotherapy (Group B)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Chemotherapy (Group A)
Number of subjects: 21
Study: 6135690

Group type: EXPERIMENTAL
Intervention: Clobazam (mean daily dose: 59 mg)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Diazepam (mean daily dose: 25 mg)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 31481581

Group type: EXPERIMENTAL
Intervention: BRAFV600 mutated patients (35 patients, 100 lesions)
Number of subjects: 70

Group type: COMPARATOR
Intervention: BRAF wild-type patients (35 patients, 79 lesions)
Number of subjects: 70
Study: 29303067

Group type: EXPERIMENTAL
Intervention: Modified tumescent solution (gas‐liquid mixing tumescent solution)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Traditional tumescent solution
Number of subjects: 186
Study: 26394161

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Liraglutide
Number of subjects: 14
Study: 24518770

Group type: EXPERIMENTAL
Intervention: Structured withdrawal of desmopressin
Number of subjects: 259

Group type: COMPARATOR
Intervention: Direct withdrawal of desmopressin
Number of subjects: 259

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study: 22246690

Group type: EXPERIMENTAL
Intervention: Stenting with aggressive medical management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aggressive medical management
Number of subjects: 0
Study: 19338702

Group type: EXPERIMENTAL
Intervention: Parent management training
Number of subjects: 238
Study: 16376417

Group type: COMPARATOR
Intervention: Cisplatin (C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cisplatin plus paclitaxel (CP)
Number of subjects: 0
Study: 15191101

Group type: EXPERIMENTAL
Intervention: Protamin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (sheath removal after 3 hours)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 10815703

Group type: EXPERIMENTAL
Intervention: Alzheimer-type dementia (AD) patients
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Normal controls
Number of subjects: 10

Group type: COMPARATOR
Intervention: Semantic dementia (SD) patients
Number of subjects: 10
Study: 9010687

Group type: EXPERIMENTAL
Intervention: 0.5 mg digoxin
Number of subjects: 8

Group type: COMPARATOR
Intervention: Digitaloid mixtures (equivalent amount to digoxin)
Number of subjects: 8
Study: 6686810

Group type: EXPERIMENTAL
Intervention: Jejunal reinfusion of aspirated duodenal fluid
Number of subjects: 0

Group type: COMPARATOR
Intervention: No jejunal reinfusion of aspirated duodenal fluid (control)
Number of subjects: 0
Study: 31058652

Group type: EXPERIMENTAL
Intervention: Naloxegol
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: PEG 3350
Number of subjects: 276

Group type: COMPARATOR
Intervention: Naloxegol and PEG 3350
Number of subjects: 276
Study: 28962668

Group type: EXPERIMENTAL
Intervention: Tapering/discontinuation of antipsychotic medication using a smartphone application to monitor early warning signs of psychotic relapse
Number of subjects: 250

Group type: COMPARATOR
Intervention: Maintenance therapy with antipsychotic medication
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Tapering/discontinuation of antipsychotic medication
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Tapering/discontinuation and maintenance therapy
Number of subjects: 250
Study: 25251548

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 23
Study: 23530608

Group type: EXPERIMENTAL
Intervention: Education only
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Education and mailed sunscreen
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Education and text message reminders
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Education, mailed sunscreen, and text message reminders
Number of subjects: 100
Study: 20804524

Group type: EXPERIMENTAL
Intervention: Nurse specialists providing care for patients with UI
Number of subjects: 6
Study: 18543484

Group type: EXPERIMENTAL
Intervention: Airening Suppository (ARN)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Indomethacin suppository
Number of subjects: 54
Study: 16641323

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) adjunctive therapy at a target dose of 60 mg/kg/day
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) adjunctive therapy
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study: 14584069

Group type: EXPERIMENTAL
Intervention: Isocaloric low-fat/high-fiber diet (20% calories as fat, 25 g/day fiber, at least 8 servings of fruits/vegetables per day)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Usual diet (control group)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Isocaloric low-fat/high-fiber diet
Number of subjects: 213
Study: 11054631

Group type: EXPERIMENTAL
Intervention: Immediate stent implantation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard techniques (prolonged dilatation or emergency bypass surgery)
Number of subjects: 100
Study: 8840371

Group type: EXPERIMENTAL
Intervention: Adenosine myocardial perfusion imaging
Number of subjects: 0
Study: 1740678

Group type: EXPERIMENTAL
Intervention: rhGM‐CSF (5 days at every other cycle, dosages of 2, 4, 8, and 16 micrograms/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: rhGM‐CSF (5 days at every other cycle)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: rhGM‐CSF (8 and 16 micrograms/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: rhGM‐CSF (subcutaneous or intravenous administration)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: rhGM‐CSF
Number of subjects: 24
Study: 6342130

Group type: EXPERIMENTAL
Intervention: Metronidazole and tobramycin
Number of subjects: 97

Group type: COMPARATOR
Intervention: Metronidazole alone (placebo for tobramycin)
Number of subjects: 97
Study: 31784702

Group type: EXPERIMENTAL
Intervention: topical tacrolimus 0.1%
Number of subjects: 49

Group type: COMPARATOR
Intervention: topical cyclosporine 1%
Number of subjects: 49
Study: 30642687

Group type: EXPERIMENTAL
Intervention: Childhood sexual abuse (CSA) in women
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Childhood sexual abuse (CSA) in men
Number of subjects: 444

Group type: COMPARATOR
Intervention: Childhood physical abuse
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Needs for care
Number of subjects: 444
Study: 28411246

Group type: EXPERIMENTAL
Intervention: GDF‐15 measured at 1 month after ACS (elevated GDF‐15 >1800 ng/L)
Number of subjects: 4049

Group type: EXPERIMENTAL
Intervention: Baseline GDF‐15 levels (elevated) followed by nonelevated GDF‐15 at 1 month
Number of subjects: 4049
Study: 27254652

Group type: EXPERIMENTAL
Intervention: Active rTMS (1Hz, 20min, 20 sessions)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 12
Study: 24388594

Group type: EXPERIMENTAL
Intervention: Multidisciplinary nutritional care
Number of subjects: 82
Study: 22230187

Group type: EXPERIMENTAL
Intervention: Part C early intervention (EI) therapy
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (matched with EI therapy group)
Number of subjects: 128
Study: 20048543

Group type: EXPERIMENTAL
Intervention: Ultraflexible training shoe (Nike Free 5.0)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional training shoe
Number of subjects: 21
Study: 17263896

Group type: EXPERIMENTAL
Intervention: Parent-centered dietary modification program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Child-centered physical activity skill-development program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined program of dietary modification and physical activity skill-development
Number of subjects: 0
Study: 15802109

Group type: EXPERIMENTAL
Intervention: Self-measurement of blood pressure (SMBP) using OMRON HEM‐705CP automatic blood pressure monitor for 15 days at weeks 6 and 14.
Number of subjects: 1325

Group type: COMPARATOR
Intervention: Usual clinical practice (control group).
Number of subjects: 1325
Study: 11169930

Group type: EXPERIMENTAL
Intervention: Exemestane (EXE) 25 mg per day
Number of subjects: 769

Group type: COMPARATOR
Intervention: Megestrol acetate (MA) 40 mg four times daily
Number of subjects: 769
Study: 10209938

Group type: EXPERIMENTAL
Intervention: Arginine infusion (20 g over 2 hours)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Baseline levels of nitrites, endothelin, and E-selectin
Number of subjects: 24
Study: 7933426

Group type: COMPARATOR
Intervention: Cholestyramine resin (placebo-controlled)
Number of subjects: 1899
Study: 3252755

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 750 mg single oral dose
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 30218514

Group type: EXPERIMENTAL
Intervention: Premature Infant Oral Motor Intervention (structured stimulation)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham intervention (unstructured stimulation)
Number of subjects: 30
Study: 29507779

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (GBE) with 100 mg aspirin daily
Number of subjects: 348

Group type: COMPARATOR
Intervention: 100 mg aspirin daily (Control)
Number of subjects: 348
Study: 26241263

Group type: EXPERIMENTAL
Intervention: EHR reminder for type 2 diabetes screening
Number of subjects: 847

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 847
Study: 23591306

Group type: EXPERIMENTAL
Intervention: I-gel
Number of subjects: 60

Group type: COMPARATOR
Intervention: Endotracheal intubation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: I-gel and Endotracheal intubation
Number of subjects: 60
Study: 21072235

Group type: EXPERIMENTAL
Intervention: Single dose rifampicin (SDR)
Number of subjects: 21711

Group type: EXPERIMENTAL
Intervention: Standard multidrug therapy (MDT) program with additional chemoprophylaxis
Number of subjects: 21711

Group type: EXPERIMENTAL
Intervention: Neighbours of neighbours and social contacts
Number of subjects: 21711

Group type: EXPERIMENTAL
Intervention: Next door neighbours
Number of subjects: 21711

Group type: EXPERIMENTAL
Intervention: Household contacts
Number of subjects: 21711

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21711
Study: 18946448

Group type: EXPERIMENTAL
Intervention: Short wave diathermy (SWD) and non-steroidal anti-inflammatory drugs (NSAID)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo SWD and NSAID
Number of subjects: 102
Study: 17184455

Group type: EXPERIMENTAL
Intervention: 2% glacial acetic acid, 0.1% dexamethasone and 3250 U/ml of neomycin sulphate
Number of subjects: 109

Group type: COMPARATOR
Intervention: 2% glacial acetic acid
Number of subjects: 109
Study: 14740951

Group type: EXPERIMENTAL
Intervention: DENV candidate vaccines
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: DENV-1, DENV-2, DENV-3 candidate vaccines
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: DENV-2, DENV-3, DENV-4 vaccine candidates
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: DENV-1 45AZ5 PDK 20, DENV-2 S16803 PDK 50, DENV-3 CH53489 PDK 20, DENV-4 341750 PDK 20
Number of subjects: 65
Study: 10952481

Group type: EXPERIMENTAL
Intervention: Benfotiamine (100 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Thiamine nitrate (100 mg)
Number of subjects: 20
Study: 9278568

Group type: EXPERIMENTAL
Intervention: Beta-carotene (0.11 mmol / 60 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lycopene (0.11 mmol)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combined dose of beta-carotene and lycopene (0.11 mmol each)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (Beta-carotene alone)
Number of subjects: 10
Study: 8346491

Group type: EXPERIMENTAL
Intervention: Procaterol
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (freon gas alone)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35